Detalhe da pesquisa
1.
Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism.
Mol Pharmacol
; 105(3): 179-193, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238100
2.
Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid.
J Pharmacol Exp Ther
; 388(2): 586-595, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188530
3.
Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation.
Hepatology
; 77(4): 1164-1180, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35689610
4.
FXR Friend-ChIPs in the Enterohepatic System.
Semin Liver Dis
; 43(3): 267-278, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442156
5.
In vivo mouse models to study bile acid synthesis and signaling.
Hepatobiliary Pancreat Dis Int
; 22(5): 466-473, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620226
6.
Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling.
Drug Metab Dispos
; 50(4): 456-467, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759011
7.
Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes.
Drug Metab Dispos
; 50(4): 468-477, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965924
8.
Farnesoid X receptor regulates lung macrophage activation and injury following nitrogen mustard exposure.
Toxicol Appl Pharmacol
; 454: 116208, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998709
9.
Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development.
Hepatology
; 71(2): 670-685, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206730
10.
The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Drug Metab Dispos
; 49(3): 276-286, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33376148
11.
Age modulates liver responses to asparaginase-induced amino acid stress in mice.
J Biol Chem
; 294(38): 13864-13875, 2019 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413113
12.
Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency.
Lab Invest
; 100(9): 1158-1168, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404932
13.
Bile Acid Homeostasis in a Cholesterol 7α-Hydroxylase and Sterol 27-Hydroxylase Double Knockout Mouse Model.
Hepatology
; 70(1): 389-402, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30864232
14.
Gut-specific inhibition of PPARα as a novel approach of NAFLD treatment.
Hepatology
; 77(1): 15-17, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633082
15.
Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice.
Hepatology
; 68(5): 1961-1976, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672888
16.
Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Hepatology
; 68(1): 304-316, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377207
17.
Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis.
Handb Exp Pharmacol
; 256: 325-357, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201553
18.
Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
Hepatology
; 65(3): 893-906, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28102638
19.
Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor.
Mol Pharmacol
; 92(4): 425-436, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28739572
20.
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Mol Pharmacol
; 91(2): 110-122, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932556